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Occasional Paper No. 14 – September 2005   
 
Using the National Drug Treatment Monitoring 
System (NDTMS) data in the North East 
Background 
 
Drug misuse in the UK is now a serious cause of morbidity and mortality. In response to an increase in 
the prevalence of drug misuse the Government created The National Treatment Agency for Substance 
Misuse (NTA) in 2001 to improve the availability, capacity and effectiveness of treatment for drug 
misuse in England as part of its National Drug Strategy. In April 2001 responsibility for NDTMS moved 
from the Department of Health to the NTA. In the North East region, the most significant recent change 
was the development of the North East regional NDTMS team in April 2004, under the management of 
the North East PHO.  This development coincided with the introduction of electronic data transfer.  
 
The present system requires 
all reporting treatment 
services (>110) to provide 
data electronically to the 
regional team on a monthly 
basis, using the core data set 
of 29 items (plus 1 additional 
regionally specific item).  
 
The rationale for data 
collection and monitoring has 
been to identify the number of 
people receiving structured 
treatment (as opposed to 
advice or needle exchange) 
where their primary 
presenting substance is a drug 
(excluding alcohol or tobacco)  
 to ensure that:  Service commissioning is 
effective and responsive 
to need; and  
 
 Those requiring drug 
treatment are able to 
receive it in a timely and 
appropriate manner. 
 
Beyond performance 
management the opportunity 
exists to use the NDTMS core 
dataset alongside other 
locally held data sources to 
illustrate regional and local 
variations in problematic 
substance misuse.  
 In this paper we aim to:  Provide a descriptive 
summary of the most 
pertinent results for the 
North East Region. 
 
 Highlight variation in 
provision, treatment 
outcomes and how 
individuals first make 
contact with treatment 
centres; and 
 
 Raise the profile of the 
NDTMS dataset to answer 
questions which lead to 
better treatment outcomes 
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 Summary 
 Between April 1st 2004 and 31st March 2005 9,875 people 
were receiving structured treatment for problematic 
substance misuse in the North East. 
 The majority of those receiving treatment were white (95%) 
male (73%) and under the age of thirty (61%) with little 
variation within the region in this regard. 
 There is wide variation within the North East region in rates 
of people receiving treatments. 
 The majority of people in treatment report problems resulting 
from the use of  opiates. 
 There was wide variation within the North East region in 
sources of referrals, retention of service users in treatment 
and treatment outcomes. 
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Analysis of NDTMS data 
 
Demographic characteristics of service users 
 
This section describes the demographic characteristics of individuals receiving structured treatment from 
the Drug Action Teams (DATs) in 2004/05 in the North East region.  Each individual is counted once 
[n=9,875] irrespective of the number of episodes and attendance at more than one agency.  Age is 
taken from their first contact with a treatment agency. 
 
Figure 1: Age and sex distribution of individuals receiving treatment in the North East 2004/05 
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Gender 
 
The gender composition of those receiving treatment was consistent with national findings1; over two 
thirds (73%) are male, with little variation of this figure between Drug Action Teams – from 68% in 
North Tyneside and 77% in Middlesbrough.  
 
Age 
 
The median age at first contact with the treatment agencies was 27 for males and 25 for females: 61% 
of males and 68% of females were below the age of 30 on their first contact with the treatment 
services. In 2003/04, the median age nationally of those in treatment centres was 26.802. 
 
Ethnicity 
 
The vast majority of individuals (95%) were recorded as White British, with 2% of individuals having no 
recorded ethnicity. There was no significant variation between the drug treatment agencies in this 
respect. 
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Prevalence  
 
The actual prevalence of problematic drug users (PDUs) in the population can only be estimated. Several 
methodologies exist to calculate this estimate. These methods are based on assumptions that cannot 
always be tested and they provide estimates that are inherently uncertain, but they are the best 
available approach; the figures presented in Table 1 have been calculated using the Multiple Indicator 
Method (MIM)3 sourced from the North East NTA. 
 
The estimated size of problematic drug users in the population can be used to give an indication of the 
extent to which problem drug users in a given population access treatment services, however it is 
important to keep in mind four points when using estimated populations of Problem Drug users: 
 
• Actual prevalence can only be indirectly estimated  
 
• Methods are based on assumptions that cannot always be tested 
 
• They provide estimates that are inherently uncertain  
 
• Drug Action Teams may have their own figures that differ from the ones published here 
 
Table 1: Estimated Number of Problematic Drug Users (PDUs) and number in treatment Across Drug 
Action Teams in the North East 
 
Drug Action Team 
Area 
Estimated Problem 
Drug User Population
Numbers in 
Treatment 
Percentage in 
Treatment 
Darlington  772  474 61% 
Durham 2493 1185 48% 
Gateshead 1262  872 69% 
Hartlepool  876  503 57% 
Middlesbrough 1109 1065 96% 
Newcastle upon Tyne 1900 1366 72% 
North Tyneside 1045  519 50% 
Northumberland 1518  599 39% 
Redcar and Cleveland  959  498 52% 
South Tyneside 1048  659 63% 
Stockton-on-Tees 1110  995 90% 
Sunderland 1677  798 48% 
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Figure 2: Directly Age Standardised Rate per 100,000 of individuals receiving treatment by Drug Action 
Teams Area, 2004/05 
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Rates of individuals receiving treatment vary significantly between Drug Action Teams across the region. 
Reasons for variation include the level of substance misuse in the population, the proportion of those in 
treatment (Table 1) and the quality of data collection. 
  
 
Primary Drug Use 
 
Figure 3 illustrates the main drug use of people in structured treatment across the region. 
 
While overall both nationally and regionally the majority of those receiving treatment cited opiates as 
their main drug problem4 (73% of males and 76% for females in the North East), there was some 
national variation with the North East having a higher proportion citing opiates and lower proportion 
citing crack and cocaine as the main drug problem compared to London and the Eastern region. 
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Figure 3: Main drug use across episodes by gender 2004/05  
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There was no significant variation within the region in the relative proportion of type of drug cited as the 
main drug problem. 
 
The opiates group includes 3 sub groups: heroin which comprised 94% of the total, methadone (3%) 
and other opiates e.g. morphine (3%). However users may switch between any of these three 
depending on the availability of the drugs. 
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Referral sources 
 
Figure 4 illustrates the source of referral by which people made contact with the treatment services. 
Many people made contact with more than one treatment agency and each separate contact is included 
in the analysis. 
 
The largest source of referral was ‘Self’ (38%), although there was some wide variation within the 
region in the number of self-referrals, from 21% in Sunderland and 56% in Redcar and Cleveland 
 
Figure 4: Source of Referral  
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Drug Interventions Programme (DIP) 
The Drug Interventions Programme (DIP), formerly known as the Criminal Justice Interventions 
Programme (CJIP) is a major part of the updated drug strategy for reducing drug-related crime. The 
Program aims to take advantage of opportunities within the criminal justice system for accessing drug-
misusing offenders, many of whom are difficult to access by other approaches, and moving them into 
treatment, away from drug use and crime.  
Table 2: Drug Action Teams in the North East taking part in the Drug Interventions Programme 
 
Phase one Drug Action 
Teams  (April 2003) 
Phase two Drug Action 
Teams  (April 2004) 
Phase three Drug Action 
Teams  (April 2005) 
Middlesbrough Hartlepool Gateshead 
 Newcastle  
 Stockton  
 Sunderland  
 
The Drug Interventions Programme was introduced in three phases (see table 2) with Middlesbrough 
Drug Action Team taking part in phase one, Hartlepool, Newcastle, Stockton and Sunderland joining as 
part of phase two and Gateshead joining as part phase three. North Tyneside, South Tyneside, Durham, 
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Darlington, Northumberland and Redcar & Cleveland are not part of the Drug Interventions Programme, 
but referrals do still come through the criminal justice system. 
There was wide variation in referrals from the Drug Interventions Programme and Arrest Referral which 
cannot be easily explained by the different dates at which Drug Action Teams joined the Drug 
Interventions Programme or whether or not they are part of the programme. 
 
Figure 5: Control Chart of Referrals from the Drug Intervention Programme 
Figure 5 is a Shewhart control chart where the middle line represents the regional trend and the outer 
lines are control limits set at three standard deviations about the regional trend. Any data points falling 
outside these control limits suggest variation greater than that which might be expected through purely 
random variation. 
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The control chart illustrates that there is a lower proportion of referrals through the Drug Interventions 
Programme and Arrest Referrals for Middlesbrough and Stockton compared to other Drug Action Teams 
in the Drug Interventions Programme. Hartlepool and Sunderland have the highest proportion 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Green: Part of the Drug Intervention Programme Blue: Not Part of the Drug Intervention Programme 
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Modality 
 
The specific treatments provided by the services refer only to the first in each episode as individuals may 
receive more than one type of treatment.  
 
The most common modality was ‘Specialist Prescribing’ - prescriptions from a consultant - accounting for 
over 30% of modalities, followed by 25% for GP Prescribing and 19% for structured counselling. 
 
Young people specific treatment modalities were not collected separately from adult treatment 
modalities at the time of data collection and so cannot be specifically reported on. 
 
 
Treatment Outcomes 
 
Treatment outcome is determined by the discharge reason at the end of each episode and is given 
across the North East Region as a whole. 
 
Figure 6: Discharge Reasons  
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Figure 6 illustrates that of those that had left treatment, the majority had dropped out (42%). The ratio 
of males to females dropping out of treatment does not differ significantly from the ratio of males to 
females as a whole. 
 
The second largest group was ‘Treatment Completed’ (16%), individuals comprising this group have 
completed some form of treatment but are not free of substance misuse, some will go on to have 
further treatment. 
 
Across the North East region 5% of finished episodes were recorded as ‘Treatment Completed Drug 
Free’. There was wide variation between Drug Action Teams in this regard. 
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Figure 7 illustrates the wide variation in the numbers who dropped out between Drug Action Teams, 
from over 50% in Hartlepool to less than 30% in Northumberland. 
 
There is considerable variation across the region in terms of finished episodes recorded as ‘Treatment 
Completed Drug Free’, from 0% in North Tyneside to 10% in Gateshead (CI: 8.16 - 13.09) . 
 
Figure 7: Breakdown of Discharge Reason by Drug Action Team 
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These significant differences are also illustrated in figure 8 in which the middle line represents the 
regional trend and the outer two grey lines represents and the upper and lower control limits are set at 
three standard deviations about the regional trend.  
 
Figure 8: Control Chart plotting Treatment Completed Drug Free against all discharges  
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Figure 8 illustrates that North Tyneside and Newcastle-upon-Tyne have the lowest proportion of people 
leaving treatment drug free, while Darlington, Gateshead and Durham have the highest proportion. 
 
Lengths of Treatment  
 
In common with findings from elsewhere in the country5, regionally 60% of episodes were ‘ongoing’ at 
the end of 2004/05.  
 
Figure 9: Length of Treatment by Drug Action Teams   
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Figure 9 illustrates the length of treatments in weeks by Drug Action Team. There is wide variation 
between Drug Action Teams in terms of the number of ongoing episodes and in lengths of treatments.  
Retention in treatment for twelve weeks is used as a target as there is evidence that this is the minimum 
needed to start to get good results. 
 
Some of the variation in the percentage of ongoing episodes between Drug Action Teams may be 
explained by data completeness and data quality in particular for Drug Action Teams that have seen 
agencies decommissioned and no discharge date for service users have been captured. 
 
Some of the variation in the percentage of episodes ending in less than twelve weeks may be the result 
of some Drug Action Teams having specialist ‘young people services’, where the treatment modalities 
are not designed to last more than twelve weeks.  
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Conclusion 
 
The use of NDTMS data for Public Health purposes has considerable potential in aiding our 
understanding of problematic substance misuse in relation to those receiving treatment, in particular in 
highlighting inequalities in provision and treatment outcomes. However, its greatest potential may be in 
highlighting areas for further investigation in conjunction with other data sources, to gain a fuller picture 
of substance misuse at a regional and national level, to inform public health policy and go in some way 
to reduce health inequalities. 
 
 
Recommendations  
 
 Data quality and completeness has improved dramatically but remains a concern e.g. around the 
recording of treatment outcomes. Agencies need to be supported so they have the appropriate 
staff and training in place for accurate and timely recording of data. 
 
 The NDTMS dataset should be used by commissioners and Primary Care Organisations to a 
greater extent to improve service provision within their locality. 
 
 The wide variation in terms of recorded treatment outcomes is a cause of concern, in terms of 
the numbers dropping out of treatment and the numbers completing treatment drug free. Given 
that previous research indicates that the strongest predictor of retention and completion of 
treatment was related to the agency attended not the characteristic of the client6 we recommend 
the following: 
 
o Research must be undertaken to assess if the variation in numbers dropping out of 
treatment is ‘real’ or an artefact of the way in which information is recorded differently 
between Drug Action Teams.  
 
o If the variation is ‘real’ then we recommend effective stakeholder partnerships to 
encourage the sharing of skills and lessons learnt to improve the equity of client retention 
and treatment outcomes across agencies. 
 
o Following feedback from stakeholders we recommend that where an individual has 
dropped out of treatment but is referred again to the same agency within 21 days, then 
the two episodes should be calculated as one continuous episode. 
 
 In order to make effective use of NDTMS data we recommend that the full postcode of service 
users should be added as an extra item in the North East. This would mean that service and 
public health planners can overcome problems arising from changes in geographical boundaries 
of commissioning organisations and electoral wards when analysing trends in service provision 
and treatment outcomes. 
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